Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide Plus Bevacizumab in Metastatic Melanoma Involving the CNS
NCT01048554Phase 2Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Nov 2009
- Primary completion
- Sep 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in melanoma, sponsored by Mount Sinai Medical Center. Started Nov 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01048554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048554.